Skip to main content

Table 3 Multivariable predictors of MACEs at 30 days and 3 years stratified by diabetes status

From: Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention

 

Variable

B

Adjusted HR [95%CI]

P value

30-day MACE

 All patients

APG

0.016

1.016 [1.012, 1.020]

<0.001

Creatinine

1.243

3.466 [1.121,10.716]

0.031

Age

0.33

1.034 [1.004,1.065]

0.028

Prior MI

1.442

4.229 [2.314,7.731]

<0.001

 Patients without DM

APG

0.017

1.018 [1.009,1.027]

<0.001

Prior MI

1.714

5.552 [2.211, 13.940]

<0.001

Age

0.046

1.047 [1.004,1.092]

0.032

 Patients with DM

APG

0.014

1.014 [1.008,1.020]

<0.001

Prior MI

1.338

3.813 [1.648,8.819]

0.002

Killip class 3-4

1.186

3.273 [1.299,8.246]

0.012

Prior PCI or CABG

1.728

5.628 [2.285,13.857]

<0.001

3-year MACEs

 All patients

APG

0.013

1.013 [1.010,1.015]

<0.001

LVEF

−0.20

0.980 [0.967,0.994]

0.004

Triple vessel disease or LM

0.452

1.572 [1.149,2.151]

0.005

Beta-blockers

−0.417

0.659 [0.465,0.935]

0.019

Prior MI

0.558

1.748 [1.212,2.520]

0.003

Age

0.014

1.014 [1.000,1.028]

0.043

 Patients without DM

APG

0.017

1.017 [1.013,1.021]

<0.001

LVEF

−0.029

0.972 [0.954,0.990]

0.002

Triple vessel disease or LM

0.815

2.259 [1.493,3.420]

<0.001

Hypertension

0.480

1.617 [1.068,2.448]

0.023

 Patients with DM

APG

0.009

1.009 [1.006,1.013]

<0.001

Prior MI

1.017

2.765 [1.690,4.525]

<0.001

Killip class 3-4

0.637

1.891 [1.090,3.282]

0.024

Creatinine

0.961

2.614 [1.279,5.341]

0.008

  1. APG admission plasma glucose, MACE major adverse cardiac event, DM diabetes mellitus. Other abbreviations as in Table 1